Tuberculin-induced delayed-type hypersensitivity reaction in a model of hu-PBMC-SCID mice grafted with autologous skin.
We have developed an animal model to study human delayed-type hypersensitivity reactions. Previous studies in humans have shown after tuberculin injection the presence of a mononuclear cell infiltration, with almost no eosinophils, associated with a preferential Th-1-type cytokine profile. Human skin graft obtained from tuberculin-reactive donors was grafted onto the back of severe combined immunodeficient mice. After healing, mice were reconstituted intraperitoneally with peripheral mononuclear cells. Tuberculin and diluent were injected intradermally, and skin biopsies were performed 72 hours later. Skin grafts were divided into two parts, one for immunohistochemistry and one for in situ hybridization studies. Immunohistochemistry was performed on cryostat sections using the alkaline phosphatase anti-alkaline phosphatase technique. In the tuberculin-injected sites as compared with the diluent-injected sites, there were significant increases in the number of CD45+ pan leukocytes and CD4+, CD8+, CD45RO+ T cells but not in CD68+ monocytes/macrophages and EG2 or MBP+ eosinophils. The activation markers CD25 and HLA-DR were up-regulated in the tuberculin-injected sites. In situ hybridization was performed using 35S-labeled riboprobes for interleukin (IL)-2, interferon (IFN)-gamma, IL-4, and IL-5. After tuberculin injection, a preferential Th-1-type cytokine profile was observed with significant increases in the numbers of IL-2 and IFN-gamma mRNA-expressing cells. These results are similar to those reported after tuberculin-induced delayed-type hypersensitivity in humans, suggesting that this model might be useful to study cutaneous inflammatory reaction.
Tsicopoulos
A
A
Institut Pasteur de Lille, France. anne.tsicopoulos@pasteur-lille.fr
Pestel
J
J
Fahy
O
O
Vorng
H
H
Vandenbusche
F
F
Porte
H
H
Eraldi
L
L
Wurtz
A
A
Akoum
H
H
Hamid
Q
Q
Wallaert
B
B
Tonnel
A B
AB
D000818:Animals; D015703:Antigens, CD / Q000378:metabolism; D016207:Cytokines / Q000378:metabolism*; D006684:HLA-DR Antigens / Q000378:metabolism; D006801:Humans; D006968:Hypersensitivity, Delayed / Q000276:immunology*; D007150:Immunohistochemistry; D017403:In Situ Hybridization; D007371:Interferon-gamma / Q000378:metabolism; D007376:Interleukin-2 / Q000378:metabolism; D015847:Interleukin-4 / Q000378:metabolism; D015848:Interleukin-5 / Q000378:metabolism; D007963:Leukocytes, Mononuclear / Q000378:metabolism*; D051379:Mice; D016513:Mice, SCID; D012333:RNA, Messenger / Q000032:analysis; D015375:Receptors, Interleukin-2 / Q000378:metabolism; D016038:Skin Transplantation / Q000276:immunology; D013601:T-Lymphocytes / Q000378:metabolism; D014373:Tuberculin / Q000494:pharmacology*
D015703:Antigens, CD; D016207:Cytokines; D006684:HLA-DR Antigens; D007376:Interleukin-2; D015848:Interleukin-5; D012333:RNA, Messenger; D015375:Receptors, Interleukin-2; D014373:Tuberculin; D015847:Interleukin-4; D007371:Interferon-gamma